INTRODUCTION
============

Operations requiring resternotomy account for approximately 10% of all cardiac operations, and this proportion might increase in the future \[[@b1-kjtcvs-48-25]\]. Although the risk involved in a patient's second cardiac surgery has decreased \[[@b2-kjtcvs-48-25],[@b3-kjtcvs-48-25]\], reported morbidity and mortality rates after the third or subsequent cardiac operation are still high \[[@b4-kjtcvs-48-25]\]. In addition, previous studies have demonstrated that injury during sternal re-entry or intrapericardial dissection is related to operative mortality and morbidity \[[@b1-kjtcvs-48-25]\]. The aims of this study were to evaluate operative outcomes in patients who underwent their third or subsequent cardiac operation for valvular heart disease, and to analyze whether pericardial coverage with an artificial membrane during the previous cardiac surgery improved outcomes.

METHODS
=======

1) Patient characteristics
--------------------------

Our study enrolled 149 patients (70 males and 79 females) who underwent their third to fifth cardiac operation for valvular heart disease from January 2000 to December 2012. It was the third cardiac operation for 114 patients, the fourth for 30 patients, and the fifth for five patients. Patients who had undergone previous operations for isolated coronary artery disease and aortic disease were excluded. We retrospectively reviewed all medical records and operation notes including both paper charts and electronic records. The mean age at operation was 57.0±11.3 years. Hypertension (n=30, 20.1%) and stroke (n=23, 15.4%) were common comorbidities ([Table 1](#t1-kjtcvs-48-25){ref-type="table"}). The most common cause for reoperation was para-valvular leakage of a prosthetic mitral valve (n=73, 49.0%) ([Table 2](#t2-kjtcvs-48-25){ref-type="table"}).

2) Operative strategy
---------------------

Preoperative computed tomography evaluation was performed on all patients. Patients were laid on the operation table after an external defibrillating paddle was placed on their backs. After untwisting and lifting the previous sternal wires, the sternum was divided using reciprocating and oscillating saws. In 18 patients, cardiopulmonary bypass (CPB) through the femoral (n=17) or axillary (n=1) artery was initiated before sternal re-entry at the discretion of the operating surgeon in order to prevent cardiac injury. In addition, 10 patients needed an emergency femoro-femoral bypass due to injury during retrosternal (n=7) or intrapericardial (n=3) dissection. During previous operations, the cardiac chambers of 51 patients had been covered with native pericardium and the cardiac chambers of 27 patients had been covered with a Gore Preclude expanded polytetrafluoroethylene (ePTFE) pericardial membrane (W. L. Gore and Associates Inc., Flagstaff, AZ, USA). The remaining 71 patients had no pericardial coverage from previous operations. After careful intrapericardial dissection, CPB was administered with routine aorto-bicaval cannulation. All operations were performed under moderate hypothermia and cold intermittent cardioplegic arrest. Mitral, aortic, and tricuspid valve surgery was performed in 87, 46, and 72 patients, respectively. Concomitant procedures included aortic surgery (n=13) and coronary artery bypass grafting (n=3) ([Table 3](#t3-kjtcvs-48-25){ref-type="table"}). At the end of the operation, the pericardium was fully closed if there was enough native pericardium to cover it. Otherwise, it was either left open or closed with an artificial membrane at the discretion of the operating surgeon. However, the ascending aorta was always covered with native tissue, such as the thymic fat pad, even when the pericardium was left open.

3) Evaluation of clinical outcomes
----------------------------------

Early mortality was defined as death before release from the hospital or within 30 days after surgery. We considered the following adverse intraoperative events: (1) injury to any of the four cardiac chambers; (2) injury to major vessels such as the aorta, vena cavae, arch vessels, and coronary artery; and (3) critical arrhythmias such as ventricular tachycardia and ventricular fibrillation \[[@b5-kjtcvs-48-25]\]. Early post-surgical outcomes were compared between patients who underwent their third cardiac operation (n=114) and those who underwent their fourth or fifth operation (n=35). Clinical outcomes were also compared between patients whose pericardium was left open during a previous operation (n=71) and those who had artificial membranes put in place (n=27), in order to analyze the effectiveness of pericardial coverage using an artificial membrane. Patients in whom the pericardium was only covered around the ascending aorta or along less than the upper one-third of the anterior surface of the heart were considered to have an open pericardium. Morbidities were defined as follows. Low cardiac output syndrome was defined as a cardiac index \<2.0 L/min/m^2^ or a systolic arterial pressure \<90 mmHg, requiring an intra-aortic balloon pump insertion or inotropic support using dopamine or dobutamine in quantities \>5 mg/kg/min. A postoperative cerebrovascular event was defined as a diagnosis of a new focal neurologic deficit, confirmed by a neurologist using an appropriate brain imaging technique such as computed tomography or magnetic resonance imaging. Acute kidney injury was defined as an increase in the serum creatinine level of 50% or more compared to the preoperative value or as the need for renal replacement therapy. Pneumonia was recorded if a clinical diagnosis was made with symptoms, imaging, and microbiological confirmation.

4) Statistical analysis
-----------------------

Statistical analyses were performed using the PASW SPSS ver. 18.0 (SPSS Inc., Chicago, IL, USA). Univariate analysis was performed using the chi-squared test or Fisher's exact test for categorical variables, and Student t-test for continuous variables. Multivariable analysis was performed for outcome variables that were statistically significant or nearly significant in univariate analysis; multiple linear regression was used for continuous variables and logistic regression was used for categorical variables. All preoperative and intraoperative factors, including categorical and continuous variables, were subjected to univariate analysis, and variables with a p-value \<0.10 in univariate analysis were entered into the multivariable analysis. p-values \<0.05 were considered statistically significant.

RESULTS
=======

1) Clinical outcomes
--------------------

Twenty-four adverse intraoperative events occurred in 22 patients (14.8%). The right atrium was the most frequently injured structure (n=6), followed by the innominate vein (n=5), right ventricle (n=4), and aorta (n=3). There was one occurrence of ventricular fibrillation during sternal re-entry ([Table 4](#t4-kjtcvs-48-25){ref-type="table"}). The adverse event rate was not significantly different between the third operation and fourth or fifth operations (13.2% \[15 of 114 patients\] vs. 20.0% \[7 of 35 patients\], p=0.318). Early mortality occurred in 9.4% of patients (14 of 149). The rate of early mortality was 9.6% among patients undergoing their third operation, compared to 8.6% among patients undergoing their fourth or fifth operation (p=0.848). Postoperative complications included low cardiac output syndrome (n=42, 28.2%), stroke (n=8, 5.4%), and acute kidney injury (n=12, 8.1%). There was no significant difference in the rate of either early mortality or postoperative complications according to the number of the operation ([Table 5](#t5-kjtcvs-48-25){ref-type="table"}).

2) Usefulness of pericardial coverage using an expanded polytetrafluoroethylene membrane
----------------------------------------------------------------------------------------

Clinical outcomes were compared between patients in whom the pericardium was closed with an ePTFE membrane in a previous operation (n=27) and those in whom the pericardium was left open (n=71). The only significant differences between these groups regarding preoperative risk factors were history of stroke (p=0.002) and infective endocarditis (p=0.012). No significant differences were found between the two groups regarding the incidence of intraoperative adverse events, early mortality, or postoperative complications. In addition, the preparation time for the aortic cross-clamp was longer in the group of patients whose pericardium had been previously closed, with a marginal level of significance (248±64 minutes vs. 225±59 minutes; p=0.090; *β* ±standard error= 23.396±13.680) ([Table 6](#t6-kjtcvs-48-25){ref-type="table"}). However, multivariable linear regression showed that this difference was statistically insignificant, after adjusting for other factors such as age, sex, and number of previous sternotomies (p=0.150, *β* ±standard error= 6.289±13.023) ([Table 7](#t7-kjtcvs-48-25){ref-type="table"}).

DISCUSSION
==========

This study demonstrated three main findings. The clinical outcomes of patients' third or subsequent operations for valvular heart disease were acceptable in terms of adverse intraoperative events and in-hospital mortality rates. There was no difference between the third cardiac operation and the fourth or fifth cardiac operation with regard to early outcomes, including the incidence of intraoperative adverse events, early mortality, and postoperative complications. The preventive strategy of covering the pericardium with an artificial membrane may not be necessary in order to improve clinical outcomes in subsequent reoperations.

Many studies reported that multiple reoperations are a risk factor for cardiac injury. The reported incidence of cardiac injury during the third or subsequent cardiac operation ranges from 14.0% to 15.1%, and the early mortality rate ranges from 8.9% to 9.0% \[[@b1-kjtcvs-48-25],[@b6-kjtcvs-48-25]\]. These ranges are in agreement with the present results, in which the incidence of adverse events and early mortality rate are 14.8% and 9.4%, respectively. However, in contrast to previous studies, our study revealed that the results of the fourth or fifth cardiac surgery were comparable to those of the third cardiac surgery in terms of cardiac injury, in-hospital mortality, and postoperative morbidities, although the number of subjects enrolled was relatively small.

Previous studies have reported that CPB support was used in 2.6% to 79.8% of patients during sternal re-entry \[[@b7-kjtcvs-48-25],[@b8-kjtcvs-48-25]\]. In the present study, CPB was used in 28 patients (18.8%) during sternal re-entry or mediastinal dissection. Ten of these patients (6.7%) needed emergency CPB support due to adverse intraoperative events. A previous study has evaluated the results of routine application of CPB before sternal re-entry, suggesting that extracorporeal circulation before a resternotomy can reduce the risk of major vascular structure injury, provide easy and reliable repair if injuries occur, and shorten overall operative time \[[@b9-kjtcvs-48-25]\]. However, we did not routinely apply CPB before sternal re-entry due to concerns about prolonged CPB time, the harmful effects of retrograde perfusion such as aortic dissection and embolic stroke, and access site complications such as vascular injury, wound infection, and distal malperfusion.

There is no doubt that if the native pericardium is large enough, it should be closed at the end of the operation. When performing cardiac valve surgery on a patient for the first time, the pericardium can be easily closed in most patients. However, during subsequent operations, the residual pericardium is often too small to cover the anterior surface of the heart, as shown by the fact that only one-third of the patients in the present study had undergone native pericardial closure during their previous operations. Surgeons in favor of pericardial closure argue that it has several advantages. First, closing the pericardium can minimize postoperative adhesions and provide sufficient retrosternal distance, which improves patient safety during repeated sternotomies \[[@b10-kjtcvs-48-25],[@b11-kjtcvs-48-25]\]. In addition, recompartmentalization of the intrapericardial microenvironment and the mediastinum may be facilitated by closing the pericardium, which separates the heart from extrapericardial blood and other substances, such as cytokines and proinflammatory mediators, that cause postoperative adhesions and post-pericardiotomy syndrome \[[@b12-kjtcvs-48-25],[@b13-kjtcvs-48-25]\]. Finally, some insist that cardiac hemodynamics can be improved by pericardial closure because the intact pericardium is able to modulate coupling between the left and right ventricles \[[@b14-kjtcvs-48-25]\]. The ePTFE membrane is the most widely utilized synthetic surgical membrane for pericardial closure when native pericardium is unavailable. Previous studies have shown that it has non-adhesive qualities and allows resternotomies to be performed \[[@b15-kjtcvs-48-25],[@b16-kjtcvs-48-25]\]. Despite these favorable reports, the routine application of ePTFE for pericardial closure has been called into question because some potentially crucial disadvantages have been identified. Both human \[[@b17-kjtcvs-48-25]\] and animal \[[@b18-kjtcvs-48-25]\] studies have demonstrated that ePTFE may aggravate the normal epicardial reaction, resulting in the deposition of a thick, fibrous, and often hemorrhagic layer that obscures the epicardial anatomy, interfering with safe sternal re-entry and dissection of the intrapericardial space. In the present study, we found that closing the pericardium with ePTFE did not improve the incidence of adverse events compared to leaving the pericardium open. In addition, the artificial membrane made the dissection of cardiac structures to apply the aortic cross-clamp more time-consuming, although the difference was not statistically significant. This corroborated previous findings indicating that ePTFE membranes can interfere with the epicardial anatomy \[[@b17-kjtcvs-48-25],[@b18-kjtcvs-48-25]\].

The present study has some limitations. First, this is a retrospective, observational study conducted at a single institution. Second, the number of study patients, especially the number of patients who underwent a fourth or fifth operation, was too small to allow a definite conclusion to be drawn.
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###### 

Preoperative characteristics and comorbidities of the study patients

  Variable                               Total (n=149)   3rd operation (n=114)   4th or 5th operation (n=35)   p-value
  -------------------------------------- --------------- ----------------------- ----------------------------- ---------
  Age (yr)                               57.0±11.3       56.7±11.1               58.0±12.0                     0.539
  Male:female                            79:70           64:50                   15:20                         0.168
  Risk factors                                                                                                 
   Smoking                               10 (6.7)        7 (6.1)                 3 (8.6)                       0.700
   Diabetes mellitus                     12 (8.1)        9 (7.9)                 3 (8.6)                       \>0.999
   Hypertension                          30 (20.1)       20 (17.5)               10 (28.6)                     0.155
   History of stroke                     23 (15.4)       17 (14.9)               6 (17.1)                      0.749
   Chronic kidney disease                5 (3.4)         3 (2.6)                 2 (5.7)                       0.335
   Infective endocarditis                15 (10.1)       10 (8.8)                5 (14.3)                      0.343
   Connective tissue disease             6 (4.1)         4 (3.5)                 2 (5.7)                       0.626
   New York Heart Association class ≥3   79 (53.0)       61 (53.5)               18 (51.4)                     0.829
  Ejection fraction (%)                  56.2±10.1       55.5±10.5               58.6±8.6                      0.109
  Duration from last operation (mo)      130.7±70.1      142.5±64.5              92.4±74.7                     \<0.001

Values are presented as mean±standard deviation or number (%).

###### 

Primary cause of reoperation

  Variable                                           Total (n=149)   3rd operation (n=114)   4th or 5th operation (n=35)   p-value
  -------------------------------------------------- --------------- ----------------------- ----------------------------- ---------
  Prosthetic valve failure                           115 (77.2)      80 (70.2)               35 (100.0)                    \<0.001
   Paravalvular leakage of prosthetic mitral valve   76 (51.0)       49 (43.0)               27 (77.1)                     \<0.001
   Paravalvular leakage of prosthetic aortic valve   13 (8.7)        8 (7.0)                 5 (14.3)                      0.183
   Stenosis of prosthetic aortic valve               9 (6.0)         9 (7.9)                 0                             0.117
   Stenosis of prosthetic mitral valve               4 (2.7)         4 (3.5)                 0                             0.573
   Stenosis of prosthetic tricuspid valve            3 (2.0)         3 (2.6)                 0                             \>0.999
   Infective endocarditis                            10 (6.7)        7 (6.1)                 3 (8.6)                       0.700
  Progression of native valve disease                34 (22.8)       34 (29.8)               0                             \<0.001
   Tricuspid regurgitation                           28 (18.8)       28 (24.6)               0                             \<0.001
   Aortic regurgitation                              3 (2.0)         3 (2.6)                 0                             \>0.999
   Aortic stenosis                                   2 (1.3)         2 (1.8)                 0                             \>0.999
   Mitral regurgitation                              1 (0.7)         1 (0.9)                 0                             \>0.999

Values are presented as number (%).

###### 

Operative data of the study patients

  Variable                                                                  Total (n=149)   3rd operation (n=114)   4th or 5th operation (n=35)   p-value
  ------------------------------------------------------------------------- --------------- ----------------------- ----------------------------- ---------
  Operation data                                                                                                                                  
   CPB time (min)                                                           240±97          225±77                  287±134                       0.012
   ACC time (min)                                                           130±60          125±52                  144±80                        0.109
   Preparation for ACC (min)[a)](#tfn5-kjtcvs-48-25){ref-type="table-fn"}   231±61          209±57                  259±68                        \<0.001
  Type of operation                                                                                                                               
   Single valve operation                                                   99 (66.4)       73 (64.0)               26 (74.3)                     0.261
    Mitral valve                                                            50 (33.6)       30 (26.3)               20 (57.1)                     0.001
    Aortic valve                                                            20 (13.4)       14 (12.3)               6 (17.1)                      0.460
    Tricuspid valve                                                         29 (19.5)       29 (25.4)               0                             \<0.001
   Double valve operation                                                   47 (31.5)       38 (33.3)               9 (25.7)                      0.396
    Mitral+aortic valve                                                     11 (7.4)        7 (6.1)                 4 (11.4)                      0.287
    Mitral+tricuspid valve                                                  23 (15.4)       18 (15.8)               5 (14.3)                      0.829
    Aortic+tricuspid valve                                                  13 (8.7)        13 (11.4)               0                             0.039
   Triple valve operation                                                   3 (2.6)         3 (2.6)                 0                             \>0.999
   Arrhythmia surgery                                                       6 (4.0)         6 (5.3)                 0                             0.336
   Coronary artery bypass graft                                             3 (2.0)         3 (2.6)                 0                             \>0.999
   Aortic surgery                                                           13 (8.7)        10 (8.8)                3 (8.6)                       \>0.999
  Planned CPB before sternotomy                                             18 (12.1)       14 (12.3)               4 (11.4)                      \>0.999
   Via femoral artery                                                       17 (11.4)       13 (11.4)               4 (11.4)                      \>0.999
   Via axillary artery                                                      1 (0.7)         1 (0.9)                 0                             \>0.999

Values are presented as mean±standard deviation or number (%).

CPB, cardiopulmonary bypass; ACC, aortic cross clamp.

The time spent from skin incision to starting aortic cross clamp.

###### 

Types of intraoperative adverse events in 22 patients

  Intraoperative adverse event   No.
  ------------------------------ -----
  Cardiac injuries               
   Right atrium                  6
   Innominate vein               5
   Right ventricle               4
   Aorta                         3
   Superior vena cava            1
   Inferior vena cava            1
   Innominate artery             1
   Right coronary artery         1
   Right pulmonary artery        1
  Ventricular fibrillation       1
  Total                          24

###### 

Comparison of intraoperative adverse event, early mortality, and morbidities between third and fourth or more cardiac operation

  Variable                                                3rd operation (n=114)   4th or 5th operation (n=35)   p-value
  ------------------------------------------------------- ----------------------- ----------------------------- ---------
  Intraoperative adverse event                            15 (13.2)               7 (20.0)                      0.318
  Emergency cardiopulmonary bypass due to adverse event   7 (6.1)                 3 (8.6)                       0.700
  Early mortality                                         11 (9.6)                3 (8.6)                       0.848
  Morbidity                                                                                                     
   Low cardiac output syndrome                            32 (28.1)               10 (28.6)                     0.954
   Postoperative cerebrovascular accident                 8 (7.0)                 0                             0.107
   Acute kidney injury                                    10 (8.8)                2 (5.7)                       0.561
   Reoperation for bleeding                               11 (9.6)                2 (5.7)                       0.471
   Pneumonia                                              34 (29.8)               5 (14.3)                      0.067

Values are presented as number (%).

###### 

Comparison between membrane closure and no closure groups

  Variable                                                                  Membrane closure (n=27)   No closure (n=71)   p-value
  ------------------------------------------------------------------------- ------------------------- ------------------- ---------
  Age (yr)                                                                  56.4±11.6                 57.5±11.3           0.667
  Male:female                                                               17:10                     35:36               0.226
  Risk factors                                                                                                            
   Smoking                                                                  2 (7.4)                   3 (4.2)             0.614
   Diabetes mellitus                                                        0                         8 (11.3)            0.102
   Hypertension                                                             8 (29.6)                  14 (19.7)           0.293
   History of stroke                                                        9 (33.3)                  6 (8.5)             0.002
   Chronic kidney disease                                                   1 (3.7)                   1 (1.4)             0.477
   Infective endocarditis                                                   6 (22.2)                  3 (4.2)             0.012
   Connective tissue disease                                                3 (11.1)                  2 (2.8)             0.127
   New York Heart Association class ≥3                                      10 (37.0)                 40 (56.3)           0.088
  Type of operation                                                                                                       
   Single valve operation                                                   23 (85.2)                 47 (66.2)           0.063
   Double valve operation                                                   4 (14.8)                  12 (32.4)           0.128
   Triple valve operation                                                   0                         1 (1.4)             \>0.999
  Operation data                                                                                                          
   CPB time (min)                                                           267±137                   234±91              0.164
   ACC time (min)                                                           143±83                    118±53              0.083
   Preparation for ACC (min)[a)](#tfn9-kjtcvs-48-25){ref-type="table-fn"}   248±64                    225±59              0.090
  Adverse event                                                             7 (25.9)                  13 (18.3)           0.403
   During sternotomy                                                        3 (11.1)                  7 (9.9)             \>0.999
   During intrapericardial dissection                                       4 (14.8)                  6 (8.5)             0.456
  CPB strategy                                                                                                            
   Routine CPB during sternal reentry                                       1 (3.7)                   11 (15.5)           0.170
   Emergent CPB due to adverse event                                        3 (11.1)                  7 (9.9)             \>0.999
  Early mortality                                                           4 (14.8)                  6 (8.5)             0.456
  Morbidity                                                                                                               
   Low cardiac output syndrome                                              10 (37.0)                 21 (29.6)           0.478
   Postoperative cerebrovascular accident                                   1 (3.7)                   3 (4.2)             \>0.999
   Acute kidney injury                                                      4 (14.8)                  2 (2.8)             0.047
   Bleeding                                                                 3 (11.1)                  5 (7.0)             0.681
   Pneumonia                                                                8 (29.6)                  21 (29.6)           0.996

Values are presented as mean±standard deviation or number (%).

CPB, cardiopulmonary bypass; ACC, aortic cross clamp.

The time spent from skin incision to starting aortic cross clamp.

###### 

Multivariable linear regression analysis to identify factors associated with preparation time for aortic cross clamp time in patients with no pericardial closure or artificial membrane closure during previous operation

  Variable[a)](#tfn10-kjtcvs-48-25){ref-type="table-fn"}   Univariate       Multivariable                    
  -------------------------------------------------------- ---------------- --------------- ---------------- ---------
  Artificial membrane closure                              23.396±13.680    0.090           6.289±13.023     0.630
  Age (yr)                                                 1.009±0.539      0.064           0.672±0.496      0.179
  Sex (reference=female)                                   −23.195±12.253   0.061           −25.912±11.365   0.025
  No. of previous operation                                44.795±10.396    \<0.001         44.174±10.705    \<0.001

All preoperative and intraoperative factors from were analyzed and only variables that entered into multivariable analysis were demonstrated.
